Advik Laboratories Other Announcement
MPS Pharmaa Limited filed its quarterly statement of investor complaints for the quarter ended 30th September, 2026, reporting NIL complaints.
ALFA Filings
Every announcement, straight from the exchange
Every MPS Pharma other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
MPS Pharmaa Limited filed its quarterly statement of investor complaints for the quarter ended 30th September, 2026, reporting NIL complaints.
MPS Pharmaa Limited announced the availability of its FY 2025-26 Annual Report on its website. It also requested shareholders to update their KYC and PAN details.
Advik Laboratories Ltd filed its quarterly shareholding pattern as of June 30, 2026. The filing provides the distribution of shares among promoters and public shareholders.
MPS Pharmaa Limited filed its Annual Secretarial Compliance Report for the financial year ended March 2026. The report details governance compliance and historical listing fee defaults.